These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2897191)

  • 1. Potential histamine H2-receptor antagonists: analogues of classical antagonists containing 4-substituted-3-aminofurazan moieties.
    Defilippi A; Sorba G; Calvino R; Garrone A; Gasco A; Orsetti M
    Arch Pharm (Weinheim); 1988 Feb; 321(2):77-80. PubMed ID: 2897191
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential histamine H2-receptor antagonists: synthesis and pharmacological activity of derivatives containing acylamino-furazan moieties.
    Sorba G; Fruttero R; Di Stilo A; Gasco A; Orsetti M
    Arch Pharm (Weinheim); 1992 Mar; 325(3):151-5. PubMed ID: 1353669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential histamine H2-receptor antagonists. Synthesis, structure and activity of a few open models related to classical H2-antagonists.
    Sorba G; Fruttero R; Gasco A; Orsetti M
    Arzneimittelforschung; 1989 Sep; 39(9):1092-6. PubMed ID: 2574039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine analogues, XXXV: 2-substituted histamine derivatives containing classical moieties of H2-antagonists--a novel class of H1-agonists.
    Zingel V; Elz S; Schunack W
    Arch Pharm (Weinheim); 1993 Mar; 326(3):143-51. PubMed ID: 8097625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential histamine H2-receptor antagonists: ranitidine analogues containing "semicarbazono equivalent" groups.
    Sorba G; Fruttero R; Calvino R; Gasco A; Orsetti M
    Arch Pharm (Weinheim); 1984 Jun; 317(6):496-501. PubMed ID: 6148051
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential histamine H2-receptor antagonists: twin compounds containing diaminofurazan substructure.
    Sorba G; Gasco A; Orsetti M
    Arch Pharm (Weinheim); 1989 Sep; 322(9):579-80. PubMed ID: 2575370
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tetrahydroisoquinolines as components of H2-antagonists. 27. H2-antihistaminics].
    Trumm KA; Postius S; Szelenyi I; Schunack W
    Arzneimittelforschung; 1986 Aug; 36(8):1169-74. PubMed ID: 2877673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [H2-Antihistaminics. 39. Basic substituted aryloxyalkylguanidine derivatives and analogs with H2-antagonistic action].
    Mohr R; Buschauer A; Schunack W
    Arch Pharm (Weinheim); 1988 Apr; 321(4):221-7. PubMed ID: 2901254
    [No Abstract]   [Full Text] [Related]  

  • 9. [H2-antihistaminics. 35. Synthesis and H2-antagonistic action of imidazolylmethylthioalkyl-substituted 1,2,4-triazoles].
    Bonjean J; Schunack W
    Arch Pharm (Weinheim); 1987 Jun; 320(6):554-62. PubMed ID: 2889442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guanidinothiazoles with H2-antihistaminic activity. 12: H2-antihistamines].
    Trumm KA; Schunack W
    Arzneimittelforschung; 1983; 33(2):188-90. PubMed ID: 6133522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [C-2 basically substituted thiazoles with H2-antagonistic action. 21. H2-antihistaminics].
    Trumm KA; Sattler HJ; Postius S; Szelenyi I; Schunack W
    Arzneimittelforschung; 1985; 35(3):573-7. PubMed ID: 2859863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioisosteric design of conformationally restricted pyridyltriazole histamine H2-receptor antagonists.
    Lipinski CA
    J Med Chem; 1983 Jan; 26(1):1-6. PubMed ID: 6131126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [H2 antihistamines. 28. Synthesis and H2 antagonistic action of 3-(3-piperidinomethylphenoxy)propyl-substituted carbonic acid derivatives and their analogs].
    Buschauer A; Krämer I; Schunack W
    Arch Pharm (Weinheim); 1986 May; 319(5):434-43. PubMed ID: 2873804
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis and H2 antihistaminic activity of 3-methyl derivatives of ranitidine].
    Leonardi A; Cazzulani P; Nardi D
    Boll Chim Farm; 1982 Jan; 121(1):1-9. PubMed ID: 6125159
    [No Abstract]   [Full Text] [Related]  

  • 15. Histamine H2-receptor blocking activity of ranitidine analogues containing 3-amino-4-alkylaminofurazan moieties.
    Orsetti M; Oggero L; Sorba G
    Pharmacol Res; 1989; 21(1):115-6. PubMed ID: 2566988
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis, structure and activity of a few open models related to classic H2-antagonists.
    Fruttero R; Sorba G; Gasco A
    Farmaco Sci; 1988 Dec; 43(12 Suppl):1131-40. PubMed ID: 2907740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis and H2-antihistaminic activity of ring methylated metiamide analogues. 4th communication: H2-antihistaminic agents (author's transl)].
    Schunack W; Engler H; Fritschi E
    Arzneimittelforschung; 1979; 29(4):595-8. PubMed ID: 39579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and histamine H2-antagonist activity of 4-quinazolinone derivatives.
    Ogawa N; Yoshida T; Aratani T; Koshinaka E; Kato H; Ito Y
    Chem Pharm Bull (Tokyo); 1988 Aug; 36(8):2955-67. PubMed ID: 2907306
    [No Abstract]   [Full Text] [Related]  

  • 19. H2-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives.
    Plazzi PV; Bordi F; Silva C; Morini G; Catellani PL; Vaona G; Impicciatore M
    Farmaco; 1989 Nov; 44(11):1011-30. PubMed ID: 2577150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and activity of pyridine analogues of histamine H2-receptor antagonists.
    Agrawal VK; Tang SB; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1988 Dec; 3(4):297-307. PubMed ID: 2908227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.